In vivo analysis of an MRI-visible microcatheter shows effective IA drug delivery in neuro-oncology, highlighting vascular visualization benefits.
Motivation: Traditional fluoroscopy effectively guides catheter placement in neurointerventions, but it is limited by inadequate soft tissue characterization and visualization of small intracranial vessels. MRI-guided interventions address these problems, but compatible and visible tooling hasn't been fully realized. Goal(s): Our goal was to evaluate the effectiveness of a passively-tracked microcatheter for intra-arterial (IA) drug delivery under real-time MRI guidance in vivo. Approach: Susceptibility and marker patterns were evaluated during real-time MRI guidance and super-selective injection of IA gadolinium was performed. Results: Preliminary findings in vivo demonstrated successful super-selective contrast delivery and significantly discernable tracking markers to delineate device distal tips. Impact: Successful device integration into MRI-guided procedures enables real-time intraprocedural validation of deposition parameters and blood-brain barrier (BBB) permeability. Improved treatment efficacy could benefit patients with metastatic disease or neurodegenerative disorders requiring BBB disruption and IA therapy, among many other applications.
No takes yet. Share an insight, caveat, or question.
Kilbride et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: